NCT02141295 A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT02046538 Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT01911598 A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) Status COMPLETED Phase PHASE1
NCT01889680 Safety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT01882868 A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan Status COMPLETED Phase PHASE2
NCT01836653 Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases Status COMPLETED Phase PHASE2
NCT01834014 Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases Status COMPLETED Phase NA
NCT01832948 Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT01803282 Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01802645 Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases Status UNKNOWN Phase PHASE2
NCT01729481 Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer Status UNKNOWN Phase PHASE2
NCT01679327 Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT01661114 A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers Status COMPLETED Phase PHASE2
NCT01633970 A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT01560949 Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas Status COMPLETED Phase PHASE2
NCT01554059 Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients Status COMPLETED Phase PHASE2
NCT01522989 PD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor Malignancies Status UNKNOWN Phase PHASE1
NCT01500993 Capecitabine in the Perioperative Treatment of Rectal Cancer Status COMPLETED Phase PHASE3
NCT01442935 Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases Status COMPLETED Phase PHASE2